膵臓がん治療薬の世界市場機会と2032年までの戦略Including:1) タイプ別1)タイプ別:膵神経内分泌がん治療薬、膵外分泌がん治療薬2)薬剤の組み合わせ別:3)エンドユーザー別:病院薬局;小売薬局ブリストル・マイヤーズ スクイブ社(BMS);膵神経内分泌がん治療薬;膵外分泌がん治療薬ブリストル・マイヤーズ スクイブ社; ファイザー社; アストラゼネカ社; F.ホフマン・ラ・ロシュ社; ノバルティス社Pancreatic Cancer Drugs Global Market Opportunities And Strategies To 2032Including: 1) By Type: Pancreatic Neuroendocrine Cancer Drugs; Pancreatic Exocrine Cancer Drugs2) By Drug Combination: Single; Double; Triplet; Quadruplet3) By End User: Hospital Pharmacies; Retail PharmaciesCovering: Bristol-Myers Squibb Company; Pfizer Inc.; AstraZeneca PLC; F. Hoffmann-La Roche AG; Novartis AG この調査レポートは、膵臓癌治療薬の世界市場 2032年までのビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。 購入の理由 - 12地域をカバーするこの市場に関する最も包括... もっと見る
サマリーこの調査レポートは、膵臓癌治療薬の世界市場 2032年までのビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。購入の理由 - 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がコロナウイルスによってどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように浮上し、成長していくのかを理解することができます。 - 現地のデータと分析に基づき、地域別および国別の戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。 - 最新の市場調査結果に基づいて顧客を理解する。 - 主要な競合他社とのパフォーマンスの比較 - 主要データセット間の関係を活用し、優れた戦略を立てる。 - 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。 説明 膵臓がん治療薬の最大かつ急成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社の膵癌治療薬世界市場レポートでは、これらすべての質問とその他多くの質問に回答しています。 当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略を網羅しています。市場の歴史をたどり、地域別の市場成長を予測しています。膵臓がん治療薬市場全体の中で同市場を位置づけ、他市場との比較も行っています。 本レポートは以下の章をカバーしています。 - 序論と市場の特徴 膵臓がん治療薬市場について、市場細分化、定義、解説を簡単に紹介しています。 - 主要動向 世界の膵臓がん治療薬市場を形成している主要トレンドをハイライトしています。また、今後の市場動向についても解説します。 - 世界市場の種類と成長 世界の過去(2017年~2022年)および予測(2022年~2027年)、(2027年~2032年)市場価値、過去および予測期間における市場の成長を支え、制御する促進因子および阻害因子について紹介します。 - 地域別分析 地域別の過去(2017-2022年)および予測(2022-2027年)、(2027-2032年)市場価値と成長率、市場シェア比較。 - 市場セグメンテーション 市場における薬剤の組み合わせ別、タイプ別、エンドユーザー別のセグメント別の市場価値(2017-2032年)と分析を収録。 - 地域市場の種類と成長 地域別の市場タイプ(2022年)、過去(2017年~2022年)と予測(2022年~2027年)、(2027年~2032年)の市場価値、地域内の国々の成長と市場シェア比較。アジア太平洋地域、西欧地域、東欧地域、北米地域、南米地域、中東・アフリカ地域の全地域と各地域内の主要国に関する情報を掲載しています。 - 競争環境 市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。 - 主要なM&A 本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を提供します。 - 機会と戦略 このセクションでは、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を提供します。今後5年間に競合他社が獲得すべき重要なビジネスがどこにあるかを理解することができる。 - 結論と提言 本セクションでは、調査結果に基づく結論と提言を掲載しています。また、製品提供、地理的拡大、価格提供、ターゲットグループなどの観点から、膵臓がん治療薬企業への提言を行う。 - 付録 本セクションでは、本レポートで使用したNAICSコード、略語、通貨コードの詳細を記載しています。 スコープ 対象市場 1) タイプ別タイプ別:膵神経内分泌がん治療薬、膵外分泌がん治療薬 2) 薬剤の組み合わせ別単剤;2剤;3剤;4剤 3) エンドユーザー別:病院薬局;小売薬局;その他エンドユーザー 言及された企業ブリストル・マイヤーズ スクイブ社、ファイザー社、アストラゼネカPLC、F.ホフマン・ラ・ロシュ社、ノバルティス社 国名中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ関連市場に対する市場規模および成長率、GDP比率、一人当たり支出、膵臓がん治療薬の指標比較。 データ区分: 国別および地域別の過去データと予測データ; 競合企業の市場シェア; 市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 当レポートでは、膵臓がん治療薬市場について記載・解説し、2017-2022年を過去期間、2022-2027年を予測期間とし、2027-2032年のさらなる予測を加えています。各地域および各地域内の主要経済圏の市場を評価しています。 世界の膵臓がん治療薬市場は、2017年以降年平均成長率(CAGR)6.5%で増加し、2022年には約38億7,250万ドルの規模に達した。市場は2022年の38億7,250万ドルから2027年には55億1,940万ドルに7.3%の成長率で拡大すると予想される。その後、2027年から年平均成長率6.9%で成長し、2032年には77億2,010万ドルに達すると予想される。 歴史的期間の成長は、新興市場における力強い経済成長、高齢化人口の増加、膵臓癌の有病率の増加によってもたらされた。過去期間の成長にマイナスの影響を与えた要因は、薬剤費の高騰、発展途上国における医療アクセスの低さ、コロナウイルスの大流行であった。 今後は、がん罹患率の増加、医療費の増加、政府支援の増加が市場を牽引していくだろう。今後の膵がん治療薬市場の成長を阻害する要因としては、金利上昇やロシア・ウクライナ戦争などが挙げられる。 膵がん治療薬市場は、タイプ別に膵神経内分泌がん治療薬と膵外分泌がん治療薬に区分される。膵神経内分泌がん治療薬は膵がん治療薬市場のタイプ別最大セグメントで、2022年の市場全体の95.5%にあたる36億9,890万ドルを占めた。膵外分泌がん治療薬市場は、年平均成長率7.7%で今後最も急成長するセグメントと予想される。 膵外分泌がん治療薬市場は、エンドユーザー別に病院薬局、小売薬局、その他のエンドユーザーに区分される。病院薬局市場はエンドユーザー別膵臓がん治療薬市場の最大セグメントで、2022年には市場全体の50.5%にあたる19億5,590万ドルを占める。小売薬局市場はCAGR 7.5%で今後最も急成長するセグメントと予想される。 膵がん治療薬市場は、薬剤の組み合わせにより、単剤、2剤、3剤、4剤に区分される。膵がん治療薬市場の薬剤組み合わせ別では二重が最大セグメントで、2022年には24億5,760万ドル、市場全体の63.5%を占める。年平均成長率(CAGR)7.8%で、今後最も急成長が見込まれるセグメントである。 膵がん治療薬市場において最大の地域は北米で、2022年の世界市場の40.7%を占めた。次いで西ヨーロッパ、アジア太平洋、その他の地域と続く。今後、膵臓がん治療薬市場で最も急成長する地域は中東と南米で、2022〜2027年のCAGRはそれぞれ13.5%と10.8%となる。 世界の膵がん治療薬市場は、小規模なプレーヤーが多数存在し、集中している。2021年の市場全体の61.17%は競合上位10社で占められている。ブリストル・マイヤーズ スクイブ社が市場シェア11.94%で最も大きく、ファイザー社10.69%、アストラゼネカ社10.17%、F.ホフマン・ラ・ロシュ社9.07%、ノバルティス社7.20%、アッヴィ社5.16%、メルク社2.86%、テバ・ファーマシューティカル・インダストリーズ社2.00%、アムジェン社1.42%、イーライリリー社0.67%と続く。 膵臓がん治療薬のタイプ別市場において、最大のビジネスチャンスは膵神経内分泌がん治療薬市場であり、2027年までに世界の年間売上高15億6,880万ドルを獲得する見込みである。エンドユーザー別膵臓がん治療薬市場の成長ポテンシャルのトップは病院薬局市場で、2027年までに世界の年間売上高は8億1,250万ドルに達するだろう。薬剤の組み合わせによる膵がん治療薬市場の成長ポテンシャルのトップはダブル市場で、2027年までに世界年間売上高11億2140万ドルを獲得する。膵がん治療薬の市場規模は、米国で4億6,150万ドルと最も大きく成長する。 膵臓がん治療薬市場の市場動向に基づく戦略には、膵臓がんを治療する新薬開発への注力、新規ナノメディシン治療への注力、投資拡大への注力、戦略的提携への注力、製品イノベーションへの注力などが含まれる。 膵臓がん治療薬業界におけるプレーヤーが採用する戦略には、戦略的パートナーシップや提携を通じた事業能力の強化、規制当局の承認取得を通じた膵臓がん患者への標的治療の選択肢の提供への注力、パートナーシップや提携を通じた事業能力の強化、規制当局の承認取得を通じた事業運営の強化などがある。 ビジネス・リサーチ・カンパニーは、膵臓がん治療薬企業に対し、このような機会を活用するため、膵臓がんを治療する新薬の開発に注力すること、膵臓がん治療のための新規ナノメディシン治療に注力すること、製品イノベーションに注力すること、新興市場での事業拡大を図ること、先進国市場に引き続き注力すること、戦略的提携に注力すること、価格競争力のある製品を提供すること、B2Bプロモーションを引き続き活用すること、展示会やイベントに参加すること、急成長するエンドユーザーを引き続きターゲットにすることなどを推奨している。 目次1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction And Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. Pancreatic Cancer Drugs Market Definition And Segmentations 6.4. Market Segmentation By Type 6.4.1. Pancreatic Neuroendocrine Cancer Drugs 6.4.2. Pancreatic Exocrine Cancer Drugs 6.5. Market Segmentation By End-User 6.5.1. Hospital Pharmacies 6.5.2. Retail Pharmacies 6.5.3. Other End-Users 6.6. Market Segmentation By Drug Combination 6.6.1. Single 6.6.2. Double 6.6.3. Triplet 6.6.4. Quadruplet 7. Major Market Trends 7.1. Development Of New Drugs To Treat Pancreatic Cancer 7.2. Rising Focus On Novel Nanomedicine Treatment For Pancreatic Cancer Treatment 7.3. Increasing Investments 7.4. Strategic Collaborations 7.5. Product Innovations 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2021 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global Pancreatic Cancer Drugs Market Segmentation 9.1. Global Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. Pancreatic Cancer Drugs Market, Regional and Country Analysis 10.1. Global Pancreatic Cancer Drugs Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global Pancreatic Cancer Drugs Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes Levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific Pancreatic Cancer Drugs Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes Levied 11.11.9. Corporate Tax Structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.37. Indonesia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.38. Indonesia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. Indonesia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.41. South Korea Market 11.42. South Korea Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.43. South Korea Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.44. South Korea Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.46. South Korea Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes Levied 12.2.9. Corporate Tax Structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe Pancreatic Cancer Drugs Market: Country Analysis 12.9. UK Market 12.10. UK Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe Pancreatic Cancer Drugs Market: Country Analysis 13.9. Russia Market 13.10. Russia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America Pancreatic Cancer Drugs Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America Pancreatic Cancer Drugs Market: Country Analysis 15.9. Brazil Market 15.10. Brazil Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 18.1. Company Profiles 18.2. Bristol-Myers Squibb Company 18.2.1. Company Overview 18.2.2. Products And Services 18.2.3. Financial Overview 18.3. Pfizer Inc. 18.3.1. Company Overview 18.3.2. Products And Services 18.3.3. Business Strategy 18.3.4. Financial Overview 18.4. AstraZeneca PLC 18.4.1. Company Overview 18.4.2. Products And Services 18.4.3. Business Strategy 18.4.4. Financial Overview 18.5. F. Hoffmann-La Roche AG 18.5.1. Company Overview 18.5.2. Products And Services 18.5.3. Business Strategy 18.5.4. Financial Overview 18.6. Novartis AG 18.6.1. Company Overview 18.6.2. Products And Services 18.6.3. Business Strategy 18.6.4. Financial Overview 19. Pipeline Analysis 20. Key Mergers And Acquisitions 20.1. Leap Therapeutics, Inc. Acquired Flame Biosciences, Inc. 20.2. AstraZeneca Acquired Neogene Therapeutics, Inc. 20.3. Ipsen Acquired Epizyme 20.4. Panbela Therapeutics, Inc. Acquired Cancer Prevention Pharmaceuticals, Inc. (CPP) 20.5. Servier Acquired Agios Pharmaceuticals 20.6. Boehringer Ingelheim Acquired Northern Biologics 21. Opportunities And Strategies 21.1. Global Pancreatic Cancer Drugs Market In 2027 – Countries Offering Most New Opportunities 21.2. Global Pancreatic Cancer Drugs Market In 2027 – Segments Offering Most New Opportunities 21.3. Global Pancreatic Cancer Drugs Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Pancreatic Cancer Drugs Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
SummaryPancreatic Cancer Drugs Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global Pancreatic cancer drugs market as it emerges from the COVID 19 shut down. Table of Contents1. Executive Summary2. Table Of Contents 3. List Of Figures 4. List Of Tables 5. Report Structure 6. Introduction And Market Characteristics 6.1. General Market Definition 6.2. Summary 6.3. Pancreatic Cancer Drugs Market Definition And Segmentations 6.4. Market Segmentation By Type 6.4.1. Pancreatic Neuroendocrine Cancer Drugs 6.4.2. Pancreatic Exocrine Cancer Drugs 6.5. Market Segmentation By End-User 6.5.1. Hospital Pharmacies 6.5.2. Retail Pharmacies 6.5.3. Other End-Users 6.6. Market Segmentation By Drug Combination 6.6.1. Single 6.6.2. Double 6.6.3. Triplet 6.6.4. Quadruplet 7. Major Market Trends 7.1. Development Of New Drugs To Treat Pancreatic Cancer 7.2. Rising Focus On Novel Nanomedicine Treatment For Pancreatic Cancer Treatment 7.3. Increasing Investments 7.4. Strategic Collaborations 7.5. Product Innovations 8. Global Market Size and Growth 8.1. Market Size 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million) 8.2.1. Market Drivers 2017 – 2021 8.2.2. Market Restraints 2017 – 2022 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 8.3.1. Market Drivers 2022 – 2027 8.3.2. Market Restraints 2022 – 2027 9. Global Pancreatic Cancer Drugs Market Segmentation 9.1. Global Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.2. Global Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 9.3. Global Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10. Pancreatic Cancer Drugs Market, Regional and Country Analysis 10.1. Global Pancreatic Cancer Drugs Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 10.2. Global Pancreatic Cancer Drugs Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11. Asia-Pacific Market 11.1. Summary 11.2. Market Overview 11.2.1. Region Information 11.2.2. Market Information 11.2.3. Background Information 11.2.4. Government Initiatives 11.2.5. Regulations 11.2.6. Regulatory Bodies 11.2.7. Major Associations 11.2.8. Taxes Levied 11.2.9. Corporate Tax Structure 11.2.10. Investments 11.2.11. Major Companies 11.3. Asia-Pacific Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.4. Asia-Pacific Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.5. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.6. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.7. Asia-Pacific Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.8. Asia-Pacific Pancreatic Cancer Drugs Market: Country Analysis 11.9. China Market 11.10. Summary 11.11. Market Overview 11.11.1. Country Information 11.11.2. Market Information 11.11.3. Background Information 11.11.4. Government Initiatives 11.11.5. Regulations 11.11.6. Regulatory Bodies 11.11.7. Major Associations 11.11.8. Taxes Levied 11.11.9. Corporate Tax Structure 11.11.10. Investments 11.11.11. Major Companies 11.12. China Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.13. China Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.14. China Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.15. China Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.16. China Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.17. India Market 11.18. India Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.19. India Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.20. India Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.21. India Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.22. India Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.23. Japan Market 11.24. Japan Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.25. Japan Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.26. Japan Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.27. Japan Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.28. Japan Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.29. Australia Market 11.30. Australia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.31. Australia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.32. Australia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.33. Australia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.34. Australia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.35. Indonesia Market 11.36. Indonesia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.37. Indonesia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.38. Indonesia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.39. Indonesia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.40. Indonesia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.41. South Korea Market 11.42. South Korea Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 11.43. South Korea Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 11.44. South Korea Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.45. South Korea Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 11.46. South Korea Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12. Western Europe Market 12.1. Summary 12.2. Market Overview 12.2.1. Region Information 12.2.2. Market Information 12.2.3. Background Information 12.2.4. Government Initiatives 12.2.5. Regulations 12.2.6. Regulatory Bodies 12.2.7. Major Associations 12.2.8. Taxes Levied 12.2.9. Corporate Tax Structure 12.2.10. Investments 12.2.11. Major Companies 12.3. Western Europe Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.4. Western Europe Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.5. Western Europe Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.6. Western Europe Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.7. Western Europe Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.8. Western Europe Pancreatic Cancer Drugs Market: Country Analysis 12.9. UK Market 12.10. UK Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.11. UK Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.12. UK Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.13. UK Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.14. UK Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.15. Germany Market 12.16. Germany Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.17. Germany Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.18. Germany Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.19. Germany Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.20. Germany Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.21. France Market 12.22. France Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 12.23. France Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 12.24. France Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.25. France Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 12.26. France Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13. Eastern Europe Market 13.1. Summary 13.2. Market Overview 13.2.1. Region Information 13.2.2. Market Information 13.2.3. Background Information 13.2.4. Government Initiatives 13.2.5. Regulations 13.2.6. Regulatory Bodies 13.2.7. Major Associations 13.2.8. Taxes Levied 13.2.9. Corporate Tax Structure 13.2.10. Investments 13.2.11. Major Companies 13.3. Eastern Europe Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.4. Eastern Europe Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.5. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.6. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.7. Eastern Europe Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.8. Eastern Europe Pancreatic Cancer Drugs Market: Country Analysis 13.9. Russia Market 13.10. Russia Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 13.11. Russia Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 13.12. Russia Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.13. Russia Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 13.14. Russia Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14. North America Market 14.1. Summary 14.2. Market Overview 14.2.1. Region Information 14.2.2. Market Information 14.2.3. Background Information 14.2.4. Government Initiatives 14.2.5. Regulations 14.2.6. Regulatory Bodies 14.2.7. Major Associations 14.2.8. Taxes Levied 14.2.9. Corporate Tax Structure 14.2.10. Investments 14.2.11. Major Companies 14.3. North America Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.4. North America Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.5. North America Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.6. North America Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.7. North America Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.8. North America Pancreatic Cancer Drugs Market: Country Analysis 14.9. USA Market 14.10. Summary 14.11. Market Overview 14.11.1. Country Information 14.11.2. Market Information 14.11.3. Background Information 14.11.4. Government Initiatives 14.11.5. Regulations 14.11.6. Regulatory Bodies 14.11.7. Major Associations 14.11.8. Taxes Levied 14.11.9. Corporate Tax Structure 14.11.10. Investments 14.11.11. Major Companies 14.12. USA Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 14.13. USA Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 14.14. USA Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.15. USA Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 14.16. USA Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15. South America Market 15.1. Summary 15.2. Market Overview 15.2.1. Region Information 15.2.2. Market Information 15.2.3. Background Information 15.2.4. Government Initiatives 15.2.5. Regulations 15.2.6. Regulatory Bodies 15.2.7. Major Associations 15.2.8. Taxes Levied 15.2.9. Corporate Tax Structure 15.2.10. Investments 15.2.11. Major Companies 15.3. South America Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.4. South America Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.5. South America Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.6. South America Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.7. South America Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.8. South America Pancreatic Cancer Drugs Market: Country Analysis 15.9. Brazil Market 15.10. Brazil Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 15.11. Brazil Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 15.12. Brazil Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.13. Brazil Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 15.14. Brazil Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16. Middle East Market 16.1. Summary 16.2. Market Overview 16.2.1. Region Information 16.2.2. Market Information 16.2.3. Background Information 16.2.4. Government Initiatives 16.2.5. Regulations 16.2.6. Regulatory Bodies 16.2.7. Major Associations 16.2.8. Taxes Levied 16.2.9. Corporate Tax Structure 16.2.10. Investments 16.2.11. Major Companies 16.3. Middle East Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 16.4. Middle East Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 16.5. Middle East Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.6. Middle East Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 16.7. Middle East Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17. Africa Market 17.1. Summary 17.2. Market Overview 17.2.1. Region Information 17.2.2. Market Information 17.2.3. Background Information 17.2.4. Government Initiatives 17.2.5. Regulations 17.2.6. Regulatory Bodies 17.2.7. Major Associations 17.2.8. Taxes Levied 17.2.9. Corporate Tax Structure 17.2.10. Investments 17.2.11. Major Companies 17.3. Africa Pancreatic Cancer Drugs Market, Historic Market Growth, 2017 – 2022, Value ($ Million) 17.4. Africa Pancreatic Cancer Drugs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million) 17.5. Africa Pancreatic Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.6. Africa Pancreatic Cancer Drugs Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 17.7. Africa Pancreatic Cancer Drugs Market, Segmentation By Drug Combination, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million) 18. Competitive Landscape and Company Profiles 18.1. Company Profiles 18.2. Bristol-Myers Squibb Company 18.2.1. Company Overview 18.2.2. Products And Services 18.2.3. Financial Overview 18.3. Pfizer Inc. 18.3.1. Company Overview 18.3.2. Products And Services 18.3.3. Business Strategy 18.3.4. Financial Overview 18.4. AstraZeneca PLC 18.4.1. Company Overview 18.4.2. Products And Services 18.4.3. Business Strategy 18.4.4. Financial Overview 18.5. F. Hoffmann-La Roche AG 18.5.1. Company Overview 18.5.2. Products And Services 18.5.3. Business Strategy 18.5.4. Financial Overview 18.6. Novartis AG 18.6.1. Company Overview 18.6.2. Products And Services 18.6.3. Business Strategy 18.6.4. Financial Overview 19. Pipeline Analysis 20. Key Mergers And Acquisitions 20.1. Leap Therapeutics, Inc. Acquired Flame Biosciences, Inc. 20.2. AstraZeneca Acquired Neogene Therapeutics, Inc. 20.3. Ipsen Acquired Epizyme 20.4. Panbela Therapeutics, Inc. Acquired Cancer Prevention Pharmaceuticals, Inc. (CPP) 20.5. Servier Acquired Agios Pharmaceuticals 20.6. Boehringer Ingelheim Acquired Northern Biologics 21. Opportunities And Strategies 21.1. Global Pancreatic Cancer Drugs Market In 2027 – Countries Offering Most New Opportunities 21.2. Global Pancreatic Cancer Drugs Market In 2027 – Segments Offering Most New Opportunities 21.3. Global Pancreatic Cancer Drugs Market In 2027 – Growth Strategies 21.3.1. Market Trend Based Strategies 21.3.2. Competitor Strategies 22. Pancreatic Cancer Drugs Market, Conclusions And Recommendations 22.1. Conclusions 22.2. Recommendations 22.2.1. Product 22.2.2. Place 22.2.3. Price 22.2.4. Promotion 22.2.5. People 23. Appendix 23.1. Market Data Sources 23.2. Research Methodology 23.3. Currencies 23.4. The Business Research Company 23.5. Copyright and Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(cancer)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |